Canadian scientists say the uncertainty surrounding U.S. President Donald Trump's apparent pause on federal health spending could stall research on new drugs, vaccines, and treatments for cancer, ...

In this week’s edition of InnovationRx, we look at HHS nominee Robert F. Kennedy Jr.’s first Senate confirmation hearing, the ...

A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...

Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...

I’m a health researcher. NIH’s pause on research grants could have a devastating cost. This is a potentially devastating ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

Chrystal Starbird, a cancer researcher at the University of North Carolina School of Medicine, had been preparing to serve on ...

Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...

A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of ...

An email obtained by NPR says NIH employees are subject to a travel freeze and offers of employment are being rescinded.